PerkinElmer supports your efforts to provide excellence in screening for open neural tube defects (ONTD). We supply a choice of instrument platforms to meet every laboratory’s needs for detection of alpha-fetoprotein (hAFP) both for primary screening and for follow-up testing.
Our hAFP assays offer the high performance that characterizes the DELFIA® technology. Analytical performance is particularly important in screening for open spina bifida, since improved precision leads to a reduction in the false-positive rate.
PerkinElmer DELFIA® and AutoDELFIA™ hAFP kits are for the quantitative determination of human Alpha-fetoprotein (hAFP) in maternal serum and amniotic fluid. The level of hAFP in amniotic fluid and maternal serum is elevated in connection with fetal malformations, especially neural tube defects (NTDs).
"Open Neural Tube Disorder"1-1
Products and Services